fingolimod (Diapin Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namefingolimod (Diapin Therapeutics)
Drug Alias Namesphingosine-1 phosphate receptor modulator (Diapin Therapeutics)fingolimod
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-Phosphate Receptor 1 antagonists
TargetsSphingosine 1-Phosphate Receptor 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiapin Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiapin Therapeutics LLC
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A